Detail Current and future prophylactic vaccines for hepatitis C virus (from Vaccine: Development and Therapy 2015, 5, 31-44) Bibliografi Author: Dunlop, James I. ; Owsianka, Anna M. ; Cowton, Vanessa M. ; Patel, Arvind H. Topik: Antibody; E1E2 glycoproteins; Epitope; HCV; Neutralizing antibody; Viral vector; Seminar - Thesis lit Bahasa: (EN )     Penerbit: Dove Medical Press     Tahun Terbit: 2015     Jenis: Article - diterbitkan di jurnal ilmiah internasional Fulltext: VDT-48437-current-and-future-prophylactic-vaccines-for-hepatitis-c-vir_081115.pdf (1.2MB; 0 download) Abstract The development of a vaccine is necessary to combat the global hepatitis C virus (HCV) epidemic. The key to the development of a prophylactic vaccine is understanding the immune response in those who spontaneously resolve HCV infections versus those who develop chronic disease. Several promising vaccine candidates based on the use of viral vectors are currently in Phase I and Phase II clinical trials. The recently solved structures of the E2 glycoprotein have greatly aided epitope- and antibody-based vaccine design. [seminar - thesis lit] Opini Anda Klik untuk menuliskan opini Anda tentang koleksi ini! Lihat Sejarah Pengadaan  Konversi Metadata   Kembali

Copyright © 2006, 2007 Unika Atma Jaya, all rights reserved